These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1178137)

  • 1. [Mechanism of action of drugs affecting lipid metabolism].
    Rossini L
    Minerva Med; 1975 Oct; 66(66):3458-68. PubMed ID: 1178137
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of primary hyperlipemia].
    Schneider J; Kaffarnik H
    Dtsch Med Wochenschr; 1971 May; 96(19):831-2. PubMed ID: 5574353
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypolipemic agents].
    Paoletti R; Fumagalli R; Sirtori R
    Minerva Med; 1973 Apr; 64(24):1267-75. PubMed ID: 4707410
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug therapy of dyslipidemias].
    Lenzi S
    Minerva Med; 1975 Oct; 66(66):3479-82. PubMed ID: 1178140
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of treatment of hyperlipidemias: long-term compliance and effect of lipid metabolism.
    Frantz ID
    Adv Exp Med Biol; 1977; 82():649-55. PubMed ID: 920422
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypolipidaemic agents (author's transl)].
    Tillement JP; Albengres E; Choisy H; Millart H
    Nouv Presse Med; 1980 Oct; 9(40):2947-50. PubMed ID: 7443428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hyperlipidemias: an update.
    Ranjan N
    Indian J Dermatol Venereol Leprol; 2009; 75(5):452-62. PubMed ID: 19736423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid lowering agents.
    Br Med J; 1972 Jun; 2(5814):642-3. PubMed ID: 5031693
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drugs in hyperlipidemia].
    Stuyt PM
    Ned Tijdschr Geneeskd; 1987 Sep; 131(36):1554-8. PubMed ID: 3670435
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hyperlipoproteinemias (author's transl)].
    Crepaldi G; Fellin R; Briani G; Baggio G; Baiocchi MR
    G Ital Cardiol; 1974; 4(3):332-40. PubMed ID: 4367439
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect on serum tocopherol levels of drug-induced decrease in serum lipids.
    Weiss P; Bianchine JR
    Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipid-lowering drugs. Therapeutics and adverse effects].
    Vogelberg KH
    Med Klin; 1979 Aug; 74(32-33):1171-8. PubMed ID: 224293
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemical and experimental aspects of the lipid-lowering drugs pharmacology (author's transl)].
    Jacotot B
    Sem Hop; 1979 Dec 8-15; 55(41-42):1947-55. PubMed ID: 231322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
    Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
    Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs].
    Haacke H; Kolenda KD
    Med Klin; 1976 Mar; 71(12):513-7. PubMed ID: 1263999
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of the hyperlipidemic patient.
    Berkowitz D
    Med Clin North Am; 1973 Jul; 57(4):881-92. PubMed ID: 4576152
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antilipemic agents available after the ban on clofibrate: clinical-pharmacological view].
    Mertz DP
    Fortschr Med; 1979 Apr; 97(15):695-6, 698. PubMed ID: 456970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arteriosclerosis--nicotinic acid therapy. 3. Lipolytic effects of nicotinic acid and its derivatives].
    Lundholm L
    Lakartidningen; 1971 Apr; 68(15):1746-9. PubMed ID: 5577245
    [No Abstract]   [Full Text] [Related]  

  • 19. Diet and drug therapy for hyperlipoproteinemia.
    Maha GE
    Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828
    [No Abstract]   [Full Text] [Related]  

  • 20. [AVERT study (Atorvastatin Versus Revascularization Treatment). Clinical advantage of aggressive lipid lowering].
    Z Kardiol; 1999 Mar; 88(3 Suppl):1-4. PubMed ID: 10330699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.